INVO Bioscience, Inc. (INVO) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Medical - Devices industria. La empresa tiene su sede en Sarasota, FL, United States. El CEO actual es Steven M. Shum.
INVO tiene fecha de IPO 2020-11-02, 25 empleados a tiempo completo, cotiza en el NASDAQ Capital Marke, una capitalización de mercado de $3.25M.
INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.
